+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cardiac Resynchronization Therapy Devices Market by Product (Cardiac Resynchronization Therapy Defibrillators, Cardiac Resynchronization Therapy Pacemakers), End-User (Ambulatory Surgery Centers, Hospitals & Cardiac Centers) - Forecast 2024-2030

  • PDF Icon

    Report

  • 193 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989932
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiac Resynchronization Therapy Devices Market size was estimated at USD 4.98 billion in 2023, USD 5.36 billion in 2024, and is expected to grow at a CAGR of 7.70% to reach USD 8.38 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Resynchronization Therapy Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Resynchronization Therapy Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Resynchronization Therapy Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Biotronik AG, Boston Scientific Corporation, EBR Systems, Inc., General Electric Company, Japan Lifeline Co., Ltd., Koninklijke Philips N.V., Livanova PLC, MEDICO S.R.L., Medtronic PLC, Merit Medical Systems, Inc., Microport Scientific Corporation, Osypka Medical GmbH, Siemens AG, and St. Jude Medical, LLC.

Market Segmentation & Coverage

This research report categorizes the Cardiac Resynchronization Therapy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Cardiac Resynchronization Therapy Defibrillators
    • Cardiac Resynchronization Therapy Pacemakers
  • End-User
    • Ambulatory Surgery Centers
    • Hospitals & Cardiac Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Cardiac Resynchronization Therapy Devices Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Resynchronization Therapy Devices Market?
  3. What are the technology trends and regulatory frameworks in the Cardiac Resynchronization Therapy Devices Market?
  4. What is the market share of the leading vendors in the Cardiac Resynchronization Therapy Devices Market?
  5. Which modes and strategic moves are suitable for entering the Cardiac Resynchronization Therapy Devices Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cardiac Resynchronization Therapy Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of cardiovascular and target diseases
5.1.1.2. Growing number of intensive care units globally
5.1.1.3. Surge in healthcare expenditure across developed and developing countries
5.1.2. Restraints
5.1.2.1. High cost of CRT devices
5.1.3. Opportunities
5.1.3.1. Integration of advanced technologies in cardiac resynchronization therapy devices
5.1.3.2. Introduction of new and innovative CRT devices
5.1.4. Challenges
5.1.4.1. Lack of skilled personnel to operate cardiac resynchronization therapy devices
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Cardiac Resynchronization Therapy Devices Market, by Product
6.1. Introduction
6.2. Cardiac Resynchronization Therapy Defibrillators
6.3. Cardiac Resynchronization Therapy Pacemakers
7. Cardiac Resynchronization Therapy Devices Market, by End-User
7.1. Introduction
7.2. Ambulatory Surgery Centers
7.3. Hospitals & Cardiac Centers
8. Americas Cardiac Resynchronization Therapy Devices Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Cardiac Resynchronization Therapy Devices Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Cardiac Resynchronization Therapy Devices Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Biotronik AG
12.1.3. Boston Scientific Corporation
12.1.4. EBR Systems, Inc.
12.1.5. General Electric Company
12.1.6. Japan Lifeline Co., Ltd.
12.1.7. Koninklijke Philips N.V.
12.1.8. Livanova PLC
12.1.9. MEDICO S.R.L.
12.1.10. Medtronic PLC
12.1.11. Merit Medical Systems, Inc.
12.1.12. Microport Scientific Corporation
12.1.13. Osypka Medical GmbH
12.1.14. Siemens AG
12.1.15. St. Jude Medical, LLC
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET RESEARCH PROCESS
FIGURE 2. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET DYNAMICS
FIGURE 7. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 10. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 9. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY HOSPITALS & CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. BRAZIL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. CANADA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 19. CANADA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. MEXICO CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. MEXICO CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. AUSTRALIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. CHINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. CHINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. INDIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. INDIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. INDONESIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. JAPAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. JAPAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. MALAYSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. PHILIPPINES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. SINGAPORE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. SOUTH KOREA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. TAIWAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. THAILAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. THAILAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. VIETNAM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. DENMARK CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. DENMARK CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. EGYPT CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. EGYPT CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. FINLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. FINLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. FRANCE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. FRANCE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. GERMANY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. GERMANY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. ISRAEL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. ITALY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. ITALY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. NETHERLANDS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. NIGERIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. NORWAY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. NORWAY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. POLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. POLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. QATAR CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. QATAR CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SPAIN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SPAIN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SWEDEN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SWITZERLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. TURKEY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. TURKEY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 98. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 99. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Biotronik AG
  • Boston Scientific Corporation
  • EBR Systems, Inc.
  • General Electric Company
  • Japan Lifeline Co., Ltd.
  • Koninklijke Philips N.V.
  • Livanova PLC
  • MEDICO S.R.L.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Microport Scientific Corporation
  • Osypka Medical GmbH
  • Siemens AG
  • St. Jude Medical, LLC

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.36 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.38 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal

Related Topics

Related Reports

Global Implantable Cardiac Rhythm Management Devices Market by Device (Cardiac Resynchronization Therapy, Defibrillators, Pacemakers), End-User (Ambulatory Surgical Centers, Hospitals, Speciality Cardiac Centers) - Forecast 2024-2030 - Product Image

Global Implantable Cardiac Rhythm Management Devices Market by Device (Cardiac Resynchronization Therapy, Defibrillators, Pacemakers), End-User (Ambulatory Surgical Centers, Hospitals, Speciality Cardiac Centers) - Forecast 2024-2030

  • Report
  • 196 Pages
  • Global
From
Cardiac Resynchronization Therapy (CRT) Devices - Global Strategic Business Report - Product Image

Cardiac Resynchronization Therapy (CRT) Devices - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Cardiac Resynchronization Therapy Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Cardiac Resynchronization Therapy Device Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 94 Pages
  • Global
From
Global Congestive Heart Failure Treatment Device Market by Product (Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Pacemaker), End-User (Ambulatory Surgery Center, Hospitals & Clinics) - Forecast 2024-2030 - Product Image

Global Congestive Heart Failure Treatment Device Market by Product (Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, Pacemaker), End-User (Ambulatory Surgery Center, Hospitals & Clinics) - Forecast 2024-2030

  • Report
  • 199 Pages
  • Global
From
Cardiac Resynchronization Therapy Pacemaker Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Cardiac Resynchronization Therapy Pacemaker Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 77 Pages
  • Global
From

About the Cardiac Resynchronization Therapy Device Market

The Cardiac Resynchronization Therapy Device (CRT-D) market is a subset of the larger cardiovascular device market. It is composed of devices used to treat heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. CRT-D devices are designed to improve the coordination of the heart's pumping action, allowing it to pump more efficiently. These devices are typically implanted in the chest and are connected to the heart via wires. CRT-D devices are used to treat a variety of heart conditions, including atrial fibrillation, ventricular tachycardia, and congestive heart failure. They are also used to reduce the risk of sudden cardiac death. The CRT-D market is highly competitive, with a number of major players. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, Biotronik, and Sorin Group. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.